Michael Mcgeehan Sells 20,000 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock

Milestone Scientific Inc. (NYSE:MLSS) Director Michael Mcgeehan sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, December 19th. The stock was sold at an average price of $0.78, for a total transaction of $15,600.00. Following the transaction, the director now owns 575,273 shares of the company’s stock, valued at approximately $448,712.94. This represents a 3.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Michael Mcgeehan also recently made the following trade(s):

• On Tuesday, September 24th, Michael Mcgeehan sold 209 shares of Milestone Scientific stock. The stock was sold at an average price of $1.00, for a total value of $209.00.

Milestone Scientific Price Performance

Shares of MLSS stock opened at $0.93 on Friday. Milestone Scientific Inc. has a one year low of $0.52 and a one year high of $1.10. The business’s 50 day simple moving average is $0.81 and its 200 day simple moving average is $0.86. The stock has a market capitalization of $72.05 million, a PE ratio of -13.21 and a beta of 1.10.

Wall Street Analyst Weigh In

MLSS has been the subject of several recent research reports. StockNews.com assumed coverage on Milestone Scientific in a research note on Friday. They issued a “hold” rating for the company. Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Institutional Investors Weigh In On Milestone Scientific

Institutional investors have recently modified their holdings of the company. Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the 3rd quarter worth about $91,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the 3rd quarter worth about $48,000. 5.79% of the stock is owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.